Share Price:

APNASPENAspen Pharmacare Hldgs123000 (0.00%)

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

Aspen presented with 2022 Economic Diplomacy (Global) Ubuntu Award

Stephen Saad, Aspen Group Chief Executive accepting the 2022 Economic Diplomacy (Global) Ubuntu Award Photo Credits: DIRCO

Cape Town, South Africa – JSE Limited-listed Aspen Pharmacare (APN), a global multinational specialty pharmaceutical company, has been presented with the South African Government and Department of International Relations and Cooperations’ (β€œDIRCO”) Ubuntu Award in the Economic Diplomacy (Global) category at its prestigious 6th annual awards ceremony hosted in Cape Town for this purpose. This… Continue reading Aspen presented with 2022 Economic Diplomacy (Global) Ubuntu Award

Closed Period

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.

Corporate

Our career opportunities are across the corporate spectrum, including Human Capital, Digital Technology, Legal, and Risk & Sustainability. Our employees are given the opportunity to hone their skills and develop the experience of excellence in their chosen field in the pharmaceutical industry.

View our teams below: